Merck surged 24% during the week as the CCI approved Procter & Gambal’s acqusition of 51.8% stake in the former. As a result, the stock hit a new high and closed 12% above its pivot price of Rs 2,668.
Merck surged 24% during the week as the CCI approved Procter & Gambal’s acqusition of 51.8% stake in the former. As a result, the stock hit a new high and closed 12% above its pivot price of Rs 2,668.